$QBIO Q BioMed featured in this Biopharma Update o
Post# of 94117
![](/assets/46931549/no_avatar_available_thumb.jpg)
Q BioMEd, with its technology partner Mannin Research, announced a GMP production contract had been initiated for MAN-19, a clinical grade therapeutic to treat complications caused by COVID-19. The Phase I trial is expected to begin enrolling patients in February 2021.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)